tyrosine and medroxyprogesterone acetate

tyrosine has been researched along with medroxyprogesterone acetate in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Balañá, ME; Charreau, EH; Elizalde, PV; Labriola, L; Movsichoff, F; Peters, G; Salatino, M	1
Akhan, SE; Bilgin, ME; Cakatay, U; Sivas, A; Telci, A; Turfanda, A	1

Other Studies

2 other study(ies) available for tyrosine and medroxyprogesterone acetate

Article	Year
Activation of ErbB-2 via a hierarchical interaction between ErbB-2 and type I insulin-like growth factor receptor in mammary tumor cells. Oncogene, 2001, Jan-04, Volume: 20, Issue:1 Topics: Animals; Enzyme Activation; Epithelial Cells; Female; Macromolecular Substances; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Oligodeoxyribonucleotides, Antisense; Phosphorylation; Progesterone Congeners; Receptor Cross-Talk; Receptor, ErbB-2; Receptor, IGF Type 1; Signal Transduction; Tumor Cells, Cultured; Tyrosine	2001
Postmenopausal hormone replacement therapy use decreases oxidative protein damage. Gynecologic and obstetric investigation, 2002, Volume: 54, Issue:2 Topics: Blood Proteins; Case-Control Studies; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Glutathione; Humans; Medroxyprogesterone Acetate; Middle Aged; Nitric Oxide; Oxidative Stress; Postmenopause; Sulfhydryl Compounds; Triglycerides; Tyrosine	2002

Article

Year

Activation of ErbB-2 via a hierarchical interaction between ErbB-2 and type I insulin-like growth factor receptor in mammary tumor cells.

Oncogene, 2001, Jan-04, Volume: 20, Issue:1

Topics: Animals; Enzyme Activation; Epithelial Cells; Female; Macromolecular Substances; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Oligodeoxyribonucleotides, Antisense; Phosphorylation; Progesterone Congeners; Receptor Cross-Talk; Receptor, ErbB-2; Receptor, IGF Type 1; Signal Transduction; Tumor Cells, Cultured; Tyrosine

2001

Postmenopausal hormone replacement therapy use decreases oxidative protein damage.

Gynecologic and obstetric investigation, 2002, Volume: 54, Issue:2

Topics: Blood Proteins; Case-Control Studies; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Glutathione; Humans; Medroxyprogesterone Acetate; Middle Aged; Nitric Oxide; Oxidative Stress; Postmenopause; Sulfhydryl Compounds; Triglycerides; Tyrosine

2002